NCT05226702View on ClinicalTrials.gov

Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 22, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Double Vaccinated for COVID-19 (For Phase 1 of the Study)Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
Interventions
BIOLOGICAL

COVAC-2

Intramuscular vaccine against SARS-CoV-2

BIOLOGICAL

Saline Placebo

Intramuscular injection of saline placebo

Trial Locations (3)

L7M 4Y1

Manna Research (Burlington North), Burlington

M9W 4L6

Manna Research, Toronto

B3K 6R8

Canadian Center for Vaccinology, Saskatoon

All Listed Sponsors
collaborator

Government of Canada

OTHER_GOV

collaborator

Government of Saskatchewan

OTHER_GOV

collaborator

Vaccine Formulation Institute (VFI)

UNKNOWN

collaborator

Seppic

INDUSTRY

lead

University of Saskatchewan

OTHER